Immunostimulatory oligonucleotides
AssigneeColey Pharmaceutical Group, Inc.
InventorsHeather Davis, Risini Weeratna
Life of this patent
Estimating the term…
Abstract
The invention relates to immunostimulatory oligonucleotides and methods of using immunostimulatory oligonucleotides to induce an antigen-specific immune response. The invention further relates to a vaccine that comprises an immunostimulatory oligonucleotide and an antigen, and comprises a pharmaceutically acceptable carrier. The immunostimulatory oligonucleotides of the invention, in some embodiments, include one or more modified linkage(s).
Claims35
1-4. (canceled)
A composition comprising an antigen and an immunostimulatory oligonucleotide comprising the nucleotide sequence of SEQ ID NO:1, and further comprising a pharmaceutically acceptable carrier.
11-14. (canceled)
(canceled)
(canceled)
(canceled)
29-38. (canceled)
(canceled)
44-46. (canceled)
(canceled)
52-104. (canceled)
Dependencies are inferred from the claim text.